Suppr超能文献

针刺联合止吐药物防治乳腺癌患者化疗所致恶心呕吐的临床观察

The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients.

作者信息

Kong Fanming, Wang Ziwei, Wang Na, Zhao Lu, Mei Qingyun, Yu Yongchao, Zhang Dou, Li Xiaojiang, Jia Yingjie

机构信息

Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

出版信息

Front Oncol. 2022 Jul 8;12:888651. doi: 10.3389/fonc.2022.888651. eCollection 2022.

Abstract

OBJECTIVE

The present study aimed to explore the effectiveness of acupuncture combined with antiemetic drugs in prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) among breast cancer patients receiving postoperative adjuvant chemotherapy.

METHODS

We retrospectively collected the clinical records of 81 postoperative breast cancer patients at our hospital from January 2021 to December 2021. These patients were divided into the acupuncture group and the control group. The efficacy of the antiemetic drugs combined with acupuncture for CINV was analysed. The primary endpoints were total, acute, and delayed nausea and vomiting grade and remission rate. Safety and overall patient quality of life were secondary endpoints.

RESULTS

During the whole observation period, compared with the control group, the frequency of nausea and vomiting was decreased in the acupuncture group (P=0.034). And the ECOG-PS score in the acupuncture group was significantly improved (P=0.004). In addition, the adverse events, such as abdominal (12.2% vs. 5.0%, P=0.252), distention (19.5% vs. 5.0%, P=0.049), and diarrhea (9.7% vs. 0, P=0.044), were decreased by acupuncture.

CONCLUSIONS

Acupuncture combined with antiemetics could reduce the incidence of CINV, improve the quality of life of patients and reduce the incidence of adverse side effects of antiemetic drugs.

摘要

目的

本研究旨在探讨针刺联合止吐药物对接受术后辅助化疗的乳腺癌患者化疗所致恶心和呕吐(CINV)的防治效果。

方法

回顾性收集我院2021年1月至2021年12月81例乳腺癌术后患者的临床资料,将其分为针刺组和对照组,分析止吐药物联合针刺对CINV的疗效。主要终点为恶心和呕吐的总分级、急性分级和延迟分级以及缓解率。安全性和患者总体生活质量为次要终点。

结果

在整个观察期内,与对照组相比,针刺组恶心和呕吐的发生率降低(P = 0.034),且针刺组的ECOG-PS评分显著改善(P = 0.004)。此外,针刺还减少了腹部不适(12.2% 对5.0%,P = 0.252)、腹胀(19.5% 对5.0%,P = 0.049)和腹泻(9.7% 对0,P = 0.044)等不良事件的发生。

结论

针刺联合止吐药物可降低CINV的发生率,提高患者生活质量,并减少止吐药物不良反应的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/215c/9304862/0038611b86c7/fonc-12-888651-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验